RadNet, Inc.

RDNT Healthcare Diagnostics & Research

RadNet, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 11.5% from fiscal 2024.

Revenue
+25.0%
EPS
−47.4%
Free cash flow
−43.2%
Total debt
+21.2%

Quarter to June 2026, against a year earlier

75.66 2.35 −3.01%
Market cap
$6.1B
P/E
0.0×
Fwd P/E
1,050×
Dividend yield
—
F-score
3/9
Altman Z
2.04
Beneish M
−2.62
Dividend safety
n/a

RadNet, Inc. (RDNT) P/E ratio

Alert me on P/E ratio

RadNet, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 4,866× (March 2024) — the current reading is the lowest in ten years.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 0.0× —
FY2024 2,328× (32.64%)
FY2023 3,456× 3,237.34%
FY2022 104× 61.64%
FY2021 64.1× —
FY2020 0.0× —
FY2019 70.0× 354.28%
FY2018 15.4× —
FY2017 0.0× —
FY2016 36.9× 1.48%

Quarterly newest first

Period P/E ratio Change
Jun 2026 0.0× —
Mar 2026 0.0× —
Dec 2025 0.0× —
Sep 2025 0.0× —
42 more quarters

Against its own ten years

Low 0.0× High 4,866×
Ten-year median 29.0×
Current reading's percentile 35

P/E ratio against peers

Company P/E ratio
RDNT RadNet, Inc. n/m
GRAL GRAIL, Inc. compare n/m
ADPT Adaptive Biotechnologies Corporation compare n/m
QGEN QIAGEN N.V. compare 25.8×
SHC Sotera Health Company compare 26.4×
CDNA CareDx, Inc. compare 31.4×
ICLR ICON PLC compare 34.9×
BLLN BillionToOne, Inc. compare 89.9×
CRL Charles River Laboratories International, Inc. compare 322×
Diagnostics & Research industry median 35.2×
Healthcare sector median 24.5×
Market median 17.8×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on RDNT